Lymphoma, Leukemia & Myeloma Congress

Lymphoma, Leukemia & Myeloma Congress The premier forum for healthcare professionals who study and manage patients with lymphoma, myeloma

For the past sixteen years, L&M has been the premier forum on the latest advances in lymphoma and myeloma. Over forty internationally-recognized leaders in molecular biology, pathology, immunology, translational and clinical research have been involved to provide expertise and guidance on recent developments in the basic science, translational medicine and clinical trials. The Congress features an interdisciplinary approach, special lectures, debates and interactive techniques to explore the controversial, the upcoming, and the exciting in myeloma, Waldenstrom’s macroglobulinemia, chronic lymphatic leukemia, lymphoma and Hodgkin’s disease.

09/17/2026

More treatment options do not necessarily make the next decision easier.

For older patients with recurrent diffuse large B-cell lymphoma, the evidence does not always provide a clear path through an evolving treatment landscape. John Leonard, MD, examines the practical question clinicians still need to resolve.

Watch his perspective, then join the lymphoma community at LL&M Congress in New York, October 13–16.
https://hubs.ly/Q04xczBs0

How is ALL care changing in 2026and what do these advances mean for treatment decisions? At the LLM Congress, “Transform...
09/16/2026

How is ALL care changing in 2026and what do these advances mean for treatment decisions?

At the LLM Congress, “Transforming ALL Care: Targeted Therapy, MRD-Guided Decisions, and CAR T Advances” will explore:
• Optimizing TKI selection and combination strategies in Ph+ ALL
• Using MRD to personalize treatment and inform transplant decisions
• Expanding lower-toxicity T-cell redirection strategies in the community

Explore emerging evidence and practical insights you can apply to the decisions you face in practice today.

Registration rates increase after Friday, September 18. Register now: https://hubs.ly/Q04xB3L30

Lymphoma encompasses many distinct diseases, so the path from diagnosis to treatment is not the same for every patient.O...
09/15/2026

Lymphoma encompasses many distinct diseases, so the path from diagnosis to treatment is not the same for every patient.

On World Lymphoma Awareness Day, we recognize those living with lymphoma and the clinicians and researchers working to improve care across its many subtypes.

09/14/2026

A regimen may be supported by clinical trial data, but applying it to an older or frail patient can raise a different set of questions.

Joseph Mikhael, MD, MEd, FRCPC, FACP, previews the practical challenge he will address at LL&M Congress. Watch now, then join him in New York for a closer look at individualizing multiple myeloma treatment.

October 13–16, 2026
https://hubs.ly/Q04xczkh0

Every child with cancer deserves care designed for their disease and their future. This September, we stand with young p...
09/12/2026

Every child with cancer deserves care designed for their disease and their future. This September, we stand with young patients, survivors, and their families.

09/11/2026

Sarah Rutherford, MD, offers a preview of what clinicians can expect to gain from her first-line diffuse large B-cell lymphoma session at LL&M Congress.

Explore the agenda: https://hubs.ly/Q04xcBhQ0

09/11/2026

First-line treatment decisions in diffuse large B-cell lymphoma are becoming increasingly nuanced. Is your approach keeping pace with the questions shaping the field?

Hear Sarah Rutherford share one question every clinician treating lymphoma should be considering, then join her at LL&M Congress in New York, October 13–16.

View the agenda: https://hubs.ly/Q04xczhS0

September brings needed attention to blood cancers and the people affected by them. We stand with patients, loved ones, ...
09/10/2026

September brings needed attention to blood cancers and the people affected by them. We stand with patients, loved ones, and the hematology professionals working to move care forward.

Six weeks from today, hematology/oncology fellows from across the country will gather at the LL&M Congress Fellows Recep...
09/01/2026

Six weeks from today, hematology/oncology fellows from across the country will gather at the LL&M Congress Fellows Reception.

Join nationally recognized faculty and fellow trainees for an evening of meaningful conversation, mentorship, and new professional connections that can continue well beyond Congress.

Tuesday, October 13
7:00 PM
New York Marriott Marquis

Attendance is complimentary, but advance RSVP is requested: https://hubs.ly/Q04vNvHW0

Why attend the LL&M Congress Fellows Reception?Some of the most valuable conversations at LL&M Congress happen beyond th...
08/29/2026

Why attend the LL&M Congress Fellows Reception?

Some of the most valuable conversations at LL&M Congress happen beyond the educational sessions. The Fellows Reception gives hematology/oncology trainees the opportunity to:

• Connect with nationally recognized faculty
• Meet fellows from institutions across the country
• Exchange clinical perspectives and research interests
• Build relationships that may lead to mentorship and future collaboration

Join us Tuesday, October 13, at 7:00 PM at the New York Marriott Marquis.

Attendance is complimentary, but advance RSVP is requested: https://hubs.ly/Q04vNCGd0

Address

811 W 7th Avenue
New York, NY

Website

Alerts

Be the first to know and let us send you an email when Lymphoma, Leukemia & Myeloma Congress posts news and promotions. Your email address will not be used for any other purpose, and you can unsubscribe at any time.

Shortcuts

Featured

Share